AITRICS
Category: AI in Healthcare
AITRICS develops AI-powered predictive healthcare solutions, including AITRICS-VC (VitalCare) for patient deterioration prediction and V.Doc for enhancing telemedicine accuracy. AITRICS was founded in 2017. The company is led by Kwang Joon Kim. Based in Seoul, South Korea. Team size: 51-200. Total funding raised: $73.1M (KRW 73.1 billion). Latest round: Series C, $23.9M, 2025-11, led by Premier Partners. Key investors include Premier Partners, Hanriver Partners, Mirae Asset Venture Investment, Shinhan Investment-BSK Investment, KB Securities-Solidus Investment, SV Investment, Mirae Asset Capital.
- Founded
- 2017
- Headquarters
- Seoul, South Korea
- Team size
- 51-200
- Total funding
- $73.1M (KRW 73.1 billion)
Value proposition
Leverages real-time electronic medical record (EMR) analysis to predict adverse health events, improving patient outcomes accuracy by 25% as per clinical trials
Products and solutions
AITRICS-VC (VitalCare) - AI patient monitoring system, V.Doc Pro - Telemedicine diagnostic enhancement tool, Customizable AI integration solutions for hospital information systems
Unique value
Combines clinical expertise of CEO Dr. Kwang Joon Kim (Severance Hospital) with AI innovation, verified by 34+ clinical validation studies and partnership with Mayo Clinic Platform
Target customer
Hospitals, healthcare providers, and telemedicine platforms seeking AI-driven clinical decision support systems
Industries served
Hospital management systems, Remote patient monitoring, Clinical decision support systems, Health informatics
Technology advantage
Proprietary EMR analysis algorithm with 98% accuracy in sepsis prediction within 4 hours, integrated with hospital workflows via API and on-premise solutions. Deployed in 130+ Korean hospitals
How they differentiate
AITRICS specializes in real-time patient deterioration prediction using vital signs data with 98% accuracy, whereas competitors often focus on medical imaging analysis or retrospective diagnostics. Their solution emphasizes predictive analytics for early intervention within 4-6 hours
Main competitors
Aidoc, Viz.ai, Tempus, Zebra Medical Vision
Key partnerships
Joint development agreement with Mayo Clinic Platform (September 2025), Partnerships with Samsung Medison for hospital system integration, Global distribution agreements with Premier Partners and Hanriver Partners, Tokyo office established March 2025 for Japan market entry
Notable customers
Severance Hospital, Samsung Medical Center, Gangnam Severance Hospital, Asan Medical Center, Ajou University Hospital
Major milestones
2017 - Founded by Kwang Joon Kim, 2021 - Launched AITRICS-VC platform, 2023 - NET certification for sepsis prediction, 2025 - $23.9M Series C funding and US market entry, 2025 - Partnership with Mayo Clinic Platform, 2025 - ISO 27001 and ISO 27701 certifications
Growth metrics
51-200 employees, 3-year CAGR of 120% in revenue, deployed in 130+ Korean hospitals
Market positioning
Positioned as a leader in predictive healthcare AI with a focus on hospital workflows and clinical decision support systems, deployed in 130+ hospitals
Geographic focus
Primarily South Korea with expansion into US and Japanese markets through subsidiaries
Patents and IP
Holds 17+ patents in AI healthcare analytics, with active filings in predictive analytics and medical data processing
About Kwang Joon Kim
Clinical Associate Professor of Geriatrics at Severance Hospital, Yonsei University; Director of Korean Society of Artificial Intelligence in Medicine; Director of Korean Society of Health Informatics & Statistics; Practicing physician with extensive clinical experience
Official website: https://aitrics.com/en/